Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Doctors at Detroit Medical Center are treating prostate cancer with cryoablation, an innovative procedure that freezes cancer cells and preserves surrounding tissue. Patients usually return home the same…
NEW YORK (Reuters Health) – A single nucleotide polymorphism in the tumor suppressor TP53 gene appears to be a risk factor for glioblastoma multiforme at an earlier age…
By Will Boggs, MD NEW YORK (Reuters Health) – Pretreatment with dacarbazine, a DNA alkylating agent, enhances vaccine-induced antitumor immunity in patients with melanoma, according to a report…
NEW YORK (Reuters Health) – The risk of intrahepatic cholangiocarcinoma is significantly elevated in patients infected with hepatitis C virus (HCV), according to a large case-control study of…
By Megan Rauscher NEW YORK (Reuters Health) – In the general population of Japan, coffee consumption is related to a lower risk of cancer of the oral cavity,…
Joint guidelines were released by the American Society of Hematology and the American Society of Clinical Oncology regarding the use of erythropoiesis-stimulating agents to treat chemotherapy-related anemia. References…
Use of skin cells to create pluripotent stem cells that look and act like embryonic stem cells have been discovered. References and Resources Takahashi K, Tanabe K, Ohnuki…
Marc R. Rosen, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, describes the relatively new technique of minimally invasive skull base surgery…
Kim Hunter-Schaedle, PhD, Chief Scientific Officer of the Children’s Tumor Foundation, discusses therapeutic options for neurofibromatosis and their progression from surgery, chemotherapy or bracing/amputation to targeted drug treatments.…
